January 26th, 2007 at 09:36am Under Heart Attack Symptoms
By National Institutes of Health (NIH) News Releases Continue Reading The National Institute of Nursing Research Launches Improved Website, January 26, 2007
January 26th, 2007 at 09:29am Under Heart Attack Symptoms
Researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, found that 0.4 milligrams (mg) a day of folic acid reduced by one third the baby’s risk of isolated cleft lip (with or without cleft palate).By National Institutes of Health (NIH) News Releases Continue Reading Folic Acid May Prevent Cleft Lip and Palate - January 26, 2007
January 26th, 2007 at 08:29am Under Heart Attack Symptoms
National Institute of Environmental Health Sciences (NIEHS), "Folic Acid May Prevent Cleft Lip and Palate" January 26, 2007By National Institutes of Health (NIH) News Releases Continue Reading Folic Acid May Prevent Cleft Lip and Palate, January 26, 2007
January 25th, 2007 at 03:15pm Under Heart Attack Symptoms
Preliminary research supported by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, has found that some smokers with damage to a part of the brain called the insula may have their addiction to nicotine practically eliminated.By National Institutes of Health (NIH) News Releases Continue Reading Damage to Specific Part of the Brain May Make Smokers ‘Forget’ to Smoke - January 25, 2007
January 25th, 2007 at 02:25pm Under Heart Attack Symptoms
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), today announced the establishment of four Centers of Excellence for Physician Information — these Centers will serve as national models to support the advancement of addiction awareness, prevention, and treatment in primary care practices.By National Institutes of Health (NIH) News Releases Continue Reading NIDA Launches Centers of Excellence for Drug Abuse Information - January 25, 2007
January 25th, 2007 at 02:15pm Under Heart Attack Symptoms
National Institute on Drug Abuse (NIDA), "Damage to Specific Part of the Brain May Make Smokers 'Forget' to Smoke" January 25, 2007By National Institutes of Health (NIH) News Releases Continue Reading Damage to Specific Part of the Brain May Make Smokers ‘Forget’ to Smoke, January 25, 2007
January 25th, 2007 at 01:25pm Under Heart Attack Symptoms
National Institute on Drug Abuse (NIDA), "NIDA Launches Centers of Excellence for Drug Abuse Information" January 25, 2007By National Institutes of Health (NIH) News Releases Continue Reading NIDA Launches Centers of Excellence for Drug Abuse Information, January 25, 2007
January 25th, 2007 at 09:40am Under Heart Attack Symptoms
National Institutes of Health Director Elias A. Zerhouni, M.D. announced that Alan M. Krensky, M.D. has been selected as the first NIH Deputy Director for the Office of Portfolio Analysis and Strategic Initiatives (OPASI). Dr. Krensky will assume his position on July 8, 2007.By National Institutes of Health (NIH) News Releases Continue Reading NIH Director Selects Dr. Alan M. Krensky as NIH Deputy Director for the Office of Portfolio Analysis and Strategic Initiatives (OPASI) - January 25, 2007
January 25th, 2007 at 08:40am Under Heart Attack Symptoms
Office of Portfolio Analysis and Strategic Initiatives (OPASI), "NIH Director Selects Dr. Alan M. Krensky as NIH Deputy Director for the Office of Portfolio Analysis and Strategic Initiatives (OPASI)" January 25, 2007By National Institutes of Health (NIH) News Releases Continue Reading NIH Director Selects Dr. Alan M. Krensky as NIH Deputy Director for the Office of Portfolio Analysis and Strategic Initiatives (OPASI), January 25, 2007
January 24th, 2007 at 04:00pm Under Heart Attack Symptoms
Positive results of a phase III cancer clinical trial in an uncommon form of leukemia were released today. The results showed that adult patients with previously untreated acute promyelocytic leukemia (APL) who had standard chemotherapy to induce remission of their disease, and then received the chemotherapy drug arsenic trioxide to maintain remission, had a significantly better event-free survival (more patients free of leukemia) and better overall survival than those who received only standard chemotherapy . The trial was sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and was led by one of its Cooperative Clinical Trials Groups — the Cancer and Leukemia Group B (CALGB).By National Institutes of Health (NIH) News Releases Continue Reading Arsenic Compound Improves Survival of Adults with Uncommon Form of Leukemia - January 24, 2007